The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through ...

Chronic Lower Back Pain (CLBP) market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis ...

Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies ...

New pacing systems have recently been specifically designed by the major companies for safe use in the MRI environment (EnRhythm, Advisa, and Revo MRI SureScan pacemakers and CapSureFix MRI leads ...

The "Abdominal Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Globus Medical (GMED – Research Report), ...

Wise covers the Healthcare sector, focusing on stocks such as Medtronic, Zimmer Biomet Holdings ... Baxter International, Inc. provides a portfolio of healthcare products. The company focuses on ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...